ArticleExperimental and therapeutic medicine2018

Targeting cysteine-rich angiogenic inducer-61 by antibody immunotherapy suppresses growth and migration of non-small cell lung cancer.

Xinpeng Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.